Day UK delivery
Days international delivery
SR-9009, which is currently under research and development, has be found to increase the level of metabolic activity in skeletal muscles of mice. Treated mice have been observed to have a reduction in adipose tissue and higher levels of Fat Free Mass (FFA). Cardiovascular improvements have also been noted. This chemical is a candidate for future treatment of metabolic disorders.
This chemical is for RESEARCH PURPOSES ONLY
Product name: S23
Molecular Formula: C18H13ClF4N2O3
Half-life: 24 hours
Appearance/color: White fine powder
Molecular Weight: 528.662 g/mol
Our products have a HPLC tested purity of ≥98.0%
You can request a copy of the HPLC reports by contacting us
Our manufacturer complies to the following:
- ISO 9001
- CQC China
What is SR9009?
SR9009, marketed as Stenabolic, is a game changing performance-enhancing drug that works to attach itself to other molecules – usually a group of proteins described as REV- ERBA – while amplifying the biochemical impact those proteins have on the human body.
Developed in Florida at the Scripps Research Institute by Prof. Thomas Buriss, the initial idea behind SR9009 was that it was going to be able to provide for a tremendous endurance in long-distance athletes that needed to “breakthrough” the current physiological barriers that were putting a limitation on overall performance.
Originally given to laboratory mice in producing a 50% longer increase in their endurance immediately, it didn’t take long for the research team to discover a number of other benefits that SR9009 brought to the table.
As soon as SR9009 was introduced to humans it had the ability to improve intercellular functions that best metabolize glucose and lipid, can better even out circadian rhythm, and can even reduce higher levels of mitochondria in individual cells.